Emerging research suggest Retatrutide , a dual stimulator targeting both GLP-1 and another hormone, could provide a significant step forward for obesity treatment. Initial patient investigations have https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide